Trial
NCT00322881
Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Dana-Farber Cancer Institute
Collaborators
Brigham and Women's Hospital; Massachusetts General Hospital
Condition
Ovarian Cancer
Intervention
Paclitaxel
Why stopped
Early closure based on audit by study investigators after 3 patients died on study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-10